XBiotech Inc. (XBIT)
- Previous Close
2.8500 - Open
2.8900 - Bid 2.0800 x 200
- Ask 3.6800 x 200
- Day's Range
2.8274 - 2.9800 - 52 Week Range
2.6500 - 9.0500 - Volume
12,189 - Avg. Volume
55,548 - Market Cap (intraday)
86.89M - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
-- - EPS (TTM)
-1.2600 - Earnings Date May 9, 2025 - May 23, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 15, 2021
- 1y Target Est
--
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
www.xbiotech.comRecent News: XBIT
View More
Performance Overview: XBIT
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XBIT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XBIT
View MoreValuation Measures
Market Cap
86.89M
Enterprise Value
-75.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.48
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-12.47%
Return on Equity (ttm)
-19.21%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-38.53M
Diluted EPS (ttm)
-1.2600
Balance Sheet and Cash Flow
Total Cash (mrq)
172.68M
Total Debt/Equity (mrq)
5.62%
Levered Free Cash Flow (ttm)
-26.29M
Research Analysis: XBIT
View MoreResearch Reports: XBIT
View MoreDaily – Vickers Top Buyers & Sellers for 10/18/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 10/07/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/29/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/23/2021
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.